Stockscreener 앱 받기
13.39
3.95%
-0.55
전일 마감가:
$13.94
열려 있는:
$13.86
하루 거래량:
734.43K
Relative Volume:
0.75
시가총액:
$1.24B
수익:
$79.76M
순이익/손실:
$-120.53M
주가수익비율:
-8.9926
EPS:
-1.489
순현금흐름:
$3.75M
1주 성능:
-3.81%
1개월 성능:
+46.50%
6개월 성능:
+80.70%
1년 성능:
+55.34%
1일 변동 폭
$13.14
$14.03
1주일 범위
$13.00
$15.35
52주 변동 폭
$6.62
$15.35
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
13.39 | 1.24B | 79.76M | -120.53M | 3.75M | -1.489 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | H.C. Wainwright | Buy |
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-07-31 | 재개 | Chardan Capital Markets | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-09-15 | 재개 | BofA Securities | Buy |
| 2019-09-03 | 개시 | Piper Jaffray | Overweight |
| 2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-03 | 개시 | Barclays | Overweight |
| 2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
MeiraGTx wins $400M investment from Oberland Capital - MSN
Latham & Watkins Advises MeiraGTx on US$400 Million Strategic Investment by Oberland Capital - Latham & Watkins LLP
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance
RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating - Moomoo
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal - Investing.com
H.C. Wainwright reiterates MeiraGTx stock rating on financing deal By Investing.com - Investing.com South Africa
MeiraGTx Holdings (MGTX) Is Up 8.5% After Securing US$425M In New Funding Pathways – Has The Bull Case Changed? - simplywall.st
Insider Sell: Stuart Naylor Sells 27,659 Shares of MeiraGTx Holdings PLC (MGTX) - GuruFocus
Form 4 MeiraGTx Holdings PLC For: 7 July By Investing.com - Investing.com Nigeria
Meiragtx chief scientific officer Naylor sells $409,470 in shares By Investing.com - Investing.com South Africa
Meiragtx chief scientific officer Naylor sells $409,470 in shares - Investing.com
MeiraGTx (MGTX) chief scientist sells 27,659 shares in pre-set 10b5-1 trades - Stock Titan
Exclusive BAC Article: MeiraGTx; AAV2-hAQP1 Q2 207 Data Xerostomia, BLA Filing 1st Half 2027, Bota-Vec Acquisition, Oberland Capital Cash Infusion, And Catalysts (NASDAQ:MGTX) - Seeking Alpha
Form 144 MeiraGTx Holdings plc For: 7 July By Investing.com - Investing.com Nigeria
MeiraGTx secures up to $400M from Oberland Capital By Investing.com - Investing.com South Africa
Meiragtx Holdings Plc shares rose 3.5% in pre-market trading. - Bitget
MGTX (NASDAQ): Proposed resale notice for 27,659 ordinary shares - Stock Titan
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec - Investing News Network
MeiraGTx Secures $400 Million Investment from Oberland Capital to Accelerate Gene Therapy Commercialization - Minichart
Oberland pours up to $400M into MeiraGTx eye gene therapies - Yahoo Finance
MeiraGTx secures up to $400M from Oberland Capital - Investing.com
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec) - The Manila Times
MeiraGTx Secures Up To $375 Million Royalty Financing, Adds $10 Million Equity, Retires Perceptive Debt - TradingView
MeiraGTx (Nasdaq: MGTX) lands $400M Oberland royalty and equity deal - Stock Titan
MeiraGTx secures up to $400M to fund gene therapy launches - Stock Titan
MGTXMeiraGTx Holdings plc Options - Finviz
Price to earnings forward of MeiraGTx Holdings plc – NASDAQ:MGTX - TradingView
Price to book forward of MeiraGTx Holdings plc – NASDAQ:MGTX - TradingView
Enterprise value to EBITDA forward of MeiraGTx Holdings plc – NASDAQ:MGTX - TradingView
MeiraGTx Holdings stock hits 52-week high at 13.72 USD - Investing.com
MeiraGTx Holdings stock hits 52-week high at 13.72 USD By Investing.com - Investing.com India
Portfolio Change Alert: Adding MeiraGTx Holdings To Portfolio (NASDAQ:MGTX) - Seeking Alpha
(MGTX) Risk Channels and Responsive Allocation - Stock Traders Daily
MeiraGTx Holdings Hits New 52-Week High of USD 13.63 - MarketsMojo
MeiraGTx Holdings Hits Day High with Strong 7.74% Intraday Surge - MarketsMojo
Form 4 MeiraGTx Holdings PLC For: 29 June By Investing.com - Investing.com India
MeiraGTx (MGTX) General Counsel granted 100,000 restricted share units - Stock Titan
MeiraGTx (MGTX) CEO Alexandria Forbes receives 980,000 RSU equity grant - Stock Titan
MeiraGTx: The Market Is Missing The Manufacturing Pivot (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings plc announced that it expects to receive $25.000002 million in funding from TPC Investments Solutions LP, TPC Investments Solutions Co-Invest LP - marketscreener.com
MeiraGTx Holdings Plc Actuals & Estimates (FWB:328) - TradingView
MeiraGTx Holdings Plc Actuals & Estimates (SWB:328) - TradingView
328 Forecast — Price Target — Prediction for 2027 - TradingView
MeiraGTx Holdings Plc Actuals & Estimates (MUN:328) - TradingView
A2JGHF Forecast — Price Target — Prediction for 2027 - TradingView
MeiraGTx Holdings Plc Actuals & Estimates (TRADEGATE:328) - TradingView
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):